Brief: Chosa Oncology Announces Decision To Postpone Release Of Interim Report For Q2 2023
Aug 27 (Reuters) - Chosa Oncology AB CHOSA.TE :
* CHOSA ONCOLOGY ANNOUNCED DECISION TO POSTPONE RELEASE OF
ITS
INTERIM REPORT FOR Q2 OF 2023.
* INTERIM REPORT PUBLICATION WILL BE RESCHEDULED TO
THURSDAY,
AUGUST 31, 2023
Source text for Eikon: ID:nWkr3LYWdR
Further company coverage: CHOSA.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chosa Oncology AB
See all newsBrief: Chosa Oncology Appoints Gerton Jönsson As New Chief Financial Officer
Brief: CHOSA Oncology AB Says Postpones Publication Of Interim Report Q4 2024
Brief: Chosa Oncology Carried Out Directed Issue Of Sek 1,55 Mln To Further Increase Business Development Activities
Brief: Chosa Oncology Announces Decision To Postpone Release Of Interim Report For Q2 2023
Brief: Chosa Oncology AB Publishes Results From Clinical Phase 2 Trial Of Liposomal Formulation In Breast Cancer, Using Predictive Marker For Cisplatin